For the Inventor, By the Inventor

Enter assignee name

Albany, NY, United States of America

Albany Molecular Research, Inc.

USPTO Granted Patents = 97

% Expired Patents = 49.5

CIPO Patents = 4

EPO Patents = 13

Trademarks = 2

Forward Citations = 433

Loading Chart...

Loading Chart...

136 inventors (with patents filed for the assignee):

Peter Guzzo (32 out of 43 patents)

Shuang Liu (20 out of 67 patents)

Bruce Francis Molino (18 out of 41 patents)

4. Thomas E D'Ambra (16 out of 22 patents)

5. Matthew Surman (14 out of 20 patents)

6. David Douglas Manning (14 out of 18 patents)

7. Alan John Henderson (10 out of 11 patents)

8. Garry M Pilling (10 out of 13 patents)

9. Matthew L Isherwood (9 out of 9 patents)

10. Harold Meckler (8 out of 25 patents)

11. Mark Hadden (7 out of 9 patents)

12. Kassoum Nacro (7 out of 7 patents)

13. Zhicai Yang (7 out of 13 patents)

14. Min Hu (6 out of 6 patents)

15. Prasad Raje (6 out of 6 patents)

Core Competencies:

Opioid Abuse Prevention

Norepinephrine Reuptake Inhibitors

Tetrahydroisoquinolines

Antibacterial Compounds

MCH-1 Antagonists

5-HT3 Receptor Modulators

Vinorelbine Derivatives

Piperidine Derivatives

Cycloalkane Analogues

Azinone-Substituted Compounds

97 patents: Sort by Forward Citations

1. 11020386 - Methods and compositions for preventing opioid abuse (2021-06-01),

2. 10695342 - Methods and compositions for preventing opioid abuse (2020-06-30),

3. 10597401 - Methods and intermediates for the preparation of omacetaxine and cephalotaxine derivatives thereof (2020-03-24),

4. 9670177 - [object Object] (2017-06-06),

5. 9650378 - (1-azinone)-substituted pyridoindoles (2017-05-16),

6. 9604960 - Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof (2017-03-28),

7. 9499531 - Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2016-11-22),

8. 9498476 - Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine (2016-11-22),

9. 9403776 - Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2016-08-02),

10. 9352049 - Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using them (2016-05-31),

11. 9296743 - (1-azinone)-substituted pyridoindoles (2016-03-29),

12. 9156812 - Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine (2015-10-13),

13. 9096546 - Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2015-08-04),

14. 9085531 - Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin (2015-07-21),

15. 9073925 - Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof (2015-07-07),

Company Overview

Albany Molecular Research, Inc. specializes in the development and manufacturing of pharmaceutical compositions, focusing on innovative solutions for various therapeutic areas. The company is engaged in advanced research on opioid abuse prevention and has expertise in norepinephrine reuptake inhibitors, antibacterial compounds, and a range of derivatives including tetrahydroisoquinolines and piperidine derivatives. Headquartered in Albany, NY, AMRI is committed to enhancing drug development processes and improving patient outcomes through its cutting-edge technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

97 Patents

#2 in Albany, NY

#239 in New York

#3,888 in US

#7,987 in the World

Albany, NY, United States of America

Albany Molecular Research, Inc.

Forward Citations = 433

136 inventors:

Peter Guzzo (32 out of 43 patents)

Shuang Liu (20 out of 67 patents)

Bruce Francis Molino (18 out of 41 patents)

4. Thomas E D'Ambra (16 out of 22 patents)

5. Matthew Surman (14 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Albany Molecular Research, Inc.. Retrieved from https://idiyas.com/company/albany-molecular-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…